Lockheed Martin Corporation (NYSE: LMT) — The Installed-Base Annuity at a Narrowing Frontier

Independent Equity Research Report date: 2026-06-12 · Price at analysis: ~$541 · Market cap: ~$125B · Enterprise value: ~$142B Sources: SEC EDGAR (FY2021–FY2025 10-Ks, Q1-2026 10-Q, DEF 14A proxy), company earnings and conference-call transcripts, and public market data.

⚡ Claude’s Take

This block is the author’s own independent opinion. It is general information, not investment advice, and not a recommendation to buy or sell any security. Everything below it — the main body of the report — is deliberately position-free and carries no recommendation or price target.

Verdict: HOLD at ~$541. A high-quality, fully-priced prime that already discounts clean execution. Accumulate-on-weakness below ~$480–500; do not chase above ~$620. Not a short — a re-arming world and an ~8% shareholder yield put a firm floor under it. Conviction: medium.

Tag: “Best annuity in the business, bought at a fair price for a franchise that’s quietly shrinking at the edge.”

Lockheed is the cheapest of the pure defense primes (~18x forward earnings vs. ~20–21x for Northrop and General Dynamics, ~26x for RTX) — but it is cheap for reasons that are real, not imaginary. The bull story writes itself: a record $193.6B backlog (2.5x sales), the only Western fifth-generation fighter in production with a sustainment tail running to the 2070s, a missiles segment compounding mid-teens on Patriot/THAAD/precision-fires replenishment, NATO marching toward 5%-of-GDP spending, and the open-ended “Golden Dome” homeland-missile-defense build. On normalized earnings of ~$29 — stripping out ~$3.6B of 2024–25 fixed-price program charges and a one-off pension settlement — you are paying ~18.7x for the best installed base in the industry plus a self-funding ~2.6% dividend (23 straight years of increases) and a buyback. That is not expensive for this quality.

The problem is what the multiple is not yet discounting on the bear side, and why I can’t get past HOLD. First, the franchise is narrowing at the frontier: Lockheed lost the NGAD sixth-generation fighter to Boeing (the F-47, March 2025) and was reportedly eliminated from the Navy’s F/A-XX — the first time in a generation the F-22/F-35 incumbent did not own the next air-dominance monopoly. The installed base is safe for 15–20 years; the forward crown is not. Second, the charges are not clearly one-off: management explicitly warns the classified Skunk Works program “may need to record additional losses,” and a company that bleeds every time it competes on fixed-price terms is telling you its moat lives in sole-source incumbency, not execution. Third, a single monopsony customer (~72% of revenue) caps structural growth at low-single-digits and the buyback — the historical EPS engine — has been cut from $7.9B (2022) to $3.0B (2025) as capex steps up and debt rises. My base-case fair value (~$507–522) sits modestly below spot, meaning the market is already paying for Lockheed to deliver its 2026 guide cleanly. That is a HOLD, not a bargain. The mispricing only appears if you buy the supercycle and believe the charge era is over — I believe one, not yet both. Flip-it-bullish trigger: the PAC-3/THAAD/PrSM multi-years definitize and FCF inflects above ~$7.5B by 2027 with no fresh reach-forward loss. Flip-it-bearish trigger: a fourth straight year of program charges, or an F-35 quantity cut below 156/year.

1. Executive Summary

Lockheed Martin is the world’s largest pure-play defense contractor — $75.0B of FY2025 revenue, ~123,000 employees, four segments (Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, Space), and a customer base that is ~72% the U.S. Government and ~28% international (overwhelmingly via U.S. foreign military sales). Its economic engine is a portfolio of multi-decade, sole-source franchises — the F-35 fighter (27% of total revenue), the PAC-3 and THAAD interceptors, the Trident II submarine-launched deterrent, and the Orion crew vehicle — protected by ITAR/clearance barriers, design-authority incumbency, and an installed-base sustainment annuity that no competitor can re-compete mid-life.

The investment debate is not about durability — it is about trajectory and price. Three facts frame it:

1. Earnings are at an artificial trough. GAAP diluted EPS was $21.49 in 2025 (and $22.31 in 2024), depressed by ~$3.6B of cumulative 2024–25 fixed-price/classified reach-forward losses plus a $479M non-cash pension settlement. Normalized earnings power is ~$29 in both years and roughly flat — the FY2026 guide of $29.35–30.25 is, by management’s own admission, ~$7 of its ~$8 year-on-year jump simply the absence of prior charges. The trailing P/E of ~26x is a denominator artifact; the honest multiple is ~18x forward.

2. The franchise edge is eroding at the frontier even as the base holds. Lockheed lost the NGAD/F-47 sixth-gen fighter to Boeing and was reportedly cut from the Navy F/A-XX — the air-dominance monopoly that defined Aeronautics for fifty years does not extend to the next generation. Offsetting this, Missiles and Fire Control is the fastest-growing segment (mid-teens CAGR guided through 2030), international demand is surging, and “Golden Dome” missile defense is a large, early-stage opportunity.

3. Capital allocation is competent but constrained. Over 2021–25 Lockheed returned $39.9B (124% of FCF), funding the ~$7.6B gap with debt (total debt roughly doubled to $21.7B; interest expense rose to $1.1B). Large M&A is effectively FTC-blocked (the Aerojet bid was abandoned in 2022; L3Harris bought it instead), so capital returns are a residual, not a strategy — and the buyback, the historical per-share engine, has been halved as capex steps up.

The stock trades at a discount to Northrop and General Dynamics for real reasons (franchise erosion, charge risk, a fading buyback), not a clean mispricing. The body that follows argues each verdict from the evidence; it takes no position and sets no target.

2. Business Overview

Lockheed Martin Corporation, formed by the 1995 merger of Lockheed and Martin Marietta, is a global aerospace, defense, security, and advanced-technologies company headquartered in Bethesda, Maryland. It is organized into four reportable segments by product type. FY2025 revenue was $75,048M (up ~5.6% from $71,043M in 2024 and $67,571M in 2023), with consolidated operating profit of $7,731M (10.3% margin).

Segment structure (FY2025: sales / operating profit / margin):

Note that the four segments sum to $6,743M of business-segment operating profit; consolidated operating profit of $7,731M is higher because of a +$1,518M net FAS/CAS pension benefit (less ~$254M of intangible amortization and other). This pension adjustment — the difference between the accounting cost of pensions (FAS) and the amount recoverable from the government under cost-accounting standards (CAS) — currently flatters reported operating profit and is an important quality caveat.

Customer and program concentration. ~72% of revenue comes from the U.S. Government, of which ~63 points is the Department of Defense (recently rebranded “Department of War”); ~28% is international, of which ~77% is foreign military sales contracted through the USG and ~23% direct commercial sales. The F-35 Lightning II is the single largest program at ~27% of total consolidated revenue and ~67% of Aeronautics — the defining concentration of the business. Lockheed has delivered 1,293 production F-35s inception-to-date against a U.S. program of record of 2,456 aircraft plus seven international partners and twelve FMS customers; backlog stands at 368 aircraft, and Lots 18/19 (296 aircraft) were definitized in September 2025.

Revenue model. Revenue is overwhelmingly recurring and program-based, recognized on a percentage-of-completion (cost-to-cost) basis over long-duration contracts. Approximately 40% of 2025 sales were cost-reimbursable (the government bears cost risk; the contractor earns a capped fee — low risk, low margin) and ~60% were fixed-price (the contractor bears overrun risk above the ceiling — the source of the recent reach-forward losses). Total backlog reached a record $193.6B at year-end 2025 (~2.5x annual sales), a fourth consecutive year of growth, with a book-to-bill of 1.2; ~37% converts to revenue within twelve months and ~60% within twenty-four.

Verdict. This is a high-visibility, contractually durable revenue base — 2.5x backlog coverage is a luxury few industrials enjoy — but with two structural features that bound its quality: a single dominant customer that caps margins in the 7–14% range (versus 40%+ in commercial-aerospace aftermarket), and a fixed-price tail that has repeatedly transferred real loss risk back onto Lockheed. The business is defensive and durable; it is not high-return in the way a commercial-aero installed base (e.g., a jet-engine aftermarket) is.

3. Industry Dynamics

Structure: a five-firm prime oligopoly. Lockheed names its primary competitors as Boeing, General Dynamics, L3Harris, Northrop Grumman, and RTX. Post-1990s consolidation left platform-prime contracting in the hands of these five, with essentially zero new entry at the platform level. Barriers are extreme and multi-layered: the capital and engineering base to integrate a fighter, a submarine, or a missile-defense system; decades of classified program history and security clearances; ITAR/export-control regimes that both gate international sales and protect incumbents; and a qualification/certification process for flight-critical and nuclear-certified hardware that takes years. A would-be entrant cannot simply buy its way in — and the one avenue that exists, horizontal M&A among the incumbents, is effectively blocked by antitrust (the Aerojet precedent,).

Demand: the best cycle in a generation. Three forces converge. First, munitions replenishment following Ukraine and the Israel/Iran conflicts — Patriot/PAC-3, GMLRS/HIMARS, JASSM/LRASM, and Javelin are being consumed and re-ordered at rates not seen since the Cold War; Lockheed reports PAC-3 production up >60% versus two years ago. Second, NATO re-armament — the alliance’s pledge toward 3.5–5% of GDP on defense (Germany, Poland, and the Baltics leading) is expanding the international pool, now ~28% of Lockheed revenue and guided toward ~30%. Third, “Golden Dome for America,” the Trump administration’s homeland missile-defense initiative, an open-ended, multi-year architecture spanning space-based interceptors, ground radars, command-and-control, and layered effectors — a TAM Lockheed is positioning across (PAC-3, THAAD, Aegis BMD, ground radars, the HELIOS laser, SDA tracking-layer satellites, and a space-based interceptor targeted to fly by 2028).

Contract economics and risk allocation. The two contract types define the risk/return profile. Cost-reimbursable work (~40%) is low-risk/low-margin: the government reimburses allowable costs and pays a fee up to a ceiling. Fixed-price work (~60%, both firm-fixed-price and fixed-price-incentive) is where the margin upside — and the loss risk — lives: above the ceiling, the contractor eats overruns. The recent reach-forward losses are concentrated in fixed-price development and classified programs, where Lockheed bid aggressively and underestimated cost. Heavy regulation (FAR/DFARS allowable-cost rules, CAS, ITAR, CMMC cybersecurity) is simultaneously a moat (it raises entry barriers) and a constraint (the monopsony buyer audits costs and caps margins; contracts can be terminated for convenience).

Marathon capital-cycle read. Capital is entering the sector — Lockheed itself is stepping capex and IRAD toward ~$5B/year to expand missile and satellite capacity — but the entry is disciplined and demand-pulled, much of it customer-funded via undefinitized contract actions or backed by multi-year framework agreements. Crucially, the normal mean-reversion mechanism (high returns attract capital, which competes margins away) is blocked by ITAR/clearance/qualification barriers and the single buyer. The watch-item is munitions over-build if the cycle turns — management itself cites the 2015 missile-demand collapse as precedent. Returns are structurally protected but structurally capped.

Verdict: a structurally good industry, with an asterisk. High barriers, an entrenched oligopoly, multi-decade program lock-in, and an exceptional demand cycle make this one of the more durable corners of industrials. But the monopsony U.S. buyer keeps most of the surplus — margins sit at 7–14%, not the 20–40% of a true commercial franchise — annual appropriations create funding and shutdown risk, and fixed-price development transfers genuine loss risk to the contractor. Good, defensive, durable; not great.

4. Competitive Position

The moat, named. Lockheed’s competitive advantage is a stack of three reinforcing Greenwald advantage types, strongest in fighters and missile defense:

• (a) Intangibles + regulatory program-incumbency. Once a platform is selected and fielded, the prime owns the design authority, the classified data, the ITAR-protected IP, and the multi-decade sustainment franchise. The F-35 is the archetype: the only Western fifth-generation fighter in production, 1,293 fielded, a 2,456-aircraft U.S. program of record, and a sustainment tail to the 2070s.
• (b) Switching costs / customer captivity. A fielded fleet’s training pipeline, depot infrastructure, logistics, spares ecosystem, and mission software make a mid-life re-compete practically impossible. The installed base is the moat — sustainment is a contracted, growing annuity (F-35 sustainment grew ~$620M in 2025 alone).
• © Economies of scale + government-granted monopoly on specific franchises: PAC-3 (the sole U.S. hit-to-kill interceptor of its class), THAAD (the sole system), Trident II D5 (the sole sea-based strategic deterrent), and Orion (the sole crewed deep-space exploration vehicle). These are effective monopolies with no second source.

The financial test. A moat must tie to a financial outcome that would deteriorate without it — and here it does, two ways. First, the $193.6B backlog (2.5x revenue, 1.2 book-to-bill) is a position no entrant could replicate. Second, and more revealing: Lockheed earns 13.8% in MFC and 10.3% in Space on sole-source franchises, but it loses money on the competitively-bid fixed-price programs (the classified Aeronautics program, the Canadian and Turkish helicopter programs). Where Lockheed competes openly on fixed-price terms, it bleeds — which proves the moat lives in incumbency and sole-source position, not in any cost or execution advantage. Strip out the sole-source franchises and the economics deteriorate sharply.

The bear core: the NGAD/F-47 loss. In March 2025 the U.S. Air Force awarded the Next Generation Air Dominance sixth-generation fighter — designated the F-47 — to Boeing, not Lockheed. The F-22/F-35 incumbent and presumed favorite lost; Lockheed received a classified debrief and chose not to protest. The Navy’s F/A-XX carrier sixth-gen fighter is also in play, and Lockheed was reportedly eliminated. The 10-K never names the loss, but the risk language is explicit — Lockheed “may be unsuccessful in obtaining new contracts or winning all or a portion of next generation programs,” and growth in “next-generation franchise programs” depends on competitions it may lose. This is genuinely damaging to the forward franchise: the Aeronautics crown jewel — the fighter monopoly — does not automatically extend to the next generation, and a competitor now holds the seat that will define air dominance into the 2070s. CEO Taiclet’s response — a self-funded “fifth-generation-plus” pitch to upgrade the F-35 to ~80% of sixth-gen capability at a fraction of the cost (his “NASCAR vs. Ferrari” framing) — is a coping strategy that concedes Lockheed did not win the clean-sheet program. Lockheed is pivoting hard to CCA drone-wingmen and Golden Dome for the next growth vector outside crewed fighters.

Why it is not yet a thesis-breaker. Three counters. (i) The F-47 is a development program a decade from meaningful revenue; the F-35 annuity (production to ~2049, sustainment to the 2070s) dwarfs it for 15+ years. (ii) Lockheed is dominant in missile defense (PAC-3/THAAD/NGI) and strategic deterrence (Trident) and well-positioned in Golden Dome — the fastest-growing pool. (iii) The loss is in one segment’s forward franchise, not the installed base. But it punctures the “Lockheed always wins the marquee fighter” premium that supported the multiple.

Competitive compare. Versus Northrop Grumman — which holds the B-21 next-gen bomber monopoly and now an edge in next-gen air — Northrop’s forward-franchise position is arguably stronger than Lockheed’s post-NGAD. Versus RTX — a diversified effectors/engines/systems supplier whose F135 engine is sole-source on the F-35 (so RTX is both a critical Lockheed supplier and a beneficiary). Versus General Dynamics — a different lane (submarines, ground vehicles, business jets). Versus Boeing — now the NGAD winner and a renewed fighter threat, though Boeing’s defense unit is execution-troubled. Lockheed remains the scale leader by revenue but is no longer the unambiguous tech-franchise leader in crewed fighters.

Verdict: durable but narrowing — eroding at the frontier. The installed-base moat (F-35 sustainment, sole-source missiles/interceptors/Trident) is wide, financially proven, and good for 15–20+ years — this is not a melting ice cube. But the forward franchise edge in crewed combat aircraft has been breached, and open-competition fixed-price execution has been poor. The moat protects the existing cash flows; the erosion is at the next-generation frontier, where Lockheed must now win on drones, missile defense, and F-35 upgrades rather than assumed fighter incumbency. The quality is high; the trajectory of the franchise edge is the genuine debate.

5. Growth History and Forward Opportunities

History. Lockheed’s top line has compounded in the low-to-mid single digits — $59.8B (2019) to $75.0B (2025), roughly 3.8% CAGR — almost entirely organic; the company is too big to acquire its way to growth. Growth has been F-35-led through the production ramp and, more recently, missiles-led as replenishment demand surged. The composition matters: the highest-quality growth in 2025 came from MFC (sole-source interceptors and precision fires) and F-35 sustainment (a contracted annuity), while the lowest-quality “growth” — revenue recognized on the classified and helicopter programs — came with losses attached.

Forward opportunities, in order of conviction:

1. Missiles and Fire Control — the genuine growth engine. Management guides MFC to a mid-teens CAGR through the end of the decade on PAC-3, THAAD, PrSM, GMLRS/HIMARS, and JASSM/LRASM, underpinned by multi-year framework agreements (some with profit-sharing above thresholds). PAC-3 production is already up >60% versus two years ago. This is funded, contracted demand — the most credible leg of the growth story.

2. International — toward 30% of the company. The NATO 5%-of-GDP trajectory and Indo-Pacific demand are expanding FMS and direct commercial sales (F-35 partners, Patriot, HIMARS, F-16). International mix is guided from ~28% toward ~30%, and international margins are often better than domestic.

3. Golden Dome — large, early, contested. A potentially multi-tens-of-billions architecture over a decade. Lockheed is positioning across the layers (interceptors, radars, C2, space-based interceptor by 2028, SDA tracking-layer satellites). But the TAM allocation among Lockheed, Northrop, RTX, and new-space entrants (Anduril, SpaceX) is unsettled, and early-stage; this is optionality, not a modeled base.

4. F-35 sustainment annuity. As the fleet grows past 1,300 aircraft toward the 2,456 program of record, the sustainment base compounds — the highest-quality, stickiest revenue Lockheed has.

5. F-35-plus and CCA drones. Self-funded upgrade and unmanned-wingman bets to recapture some of the air-dominance value lost with NGAD. Real but unproven and not yet funded as programs of record.

Verdict: respectable but capped, with a quality mix improving toward missiles. This is a ~5% top-line grower (FY2026 guide of $77.5–80B implies ~5% organic) with a genuine mid-teens compounder inside it (MFC) and real optionality (Golden Dome) — but bounded by a single budget-constrained customer, F-35 production flat at 156/year, and the loss of the next fighter franchise. High-quality growth where it is sole-source; lower-quality where it is competitively bid.

6. Financial Quality

The central quality-of-earnings question. Lockheed’s net income fell from $6,920M (2023) to $5,336M (2024) to $5,017M (2025) even as revenue rose $67.6B → $75.0B and operating profit recovered ($8,507M → $7,013M → $7,731M). The decline is not operational deterioration — it is the combination of (a) program charges suppressing operating profit and (b) three below-the-line items, decomposed below.

(a) The charges — ~$3.6B over 2024–25. These are fixed-price/classified “reach-forward” losses (recognizing the entire expected loss on a contract the moment it becomes probable):

• 2024 (~$2.0B): $1,400M on a classified program at MFC + $555M on a classified program at Aeronautics, partly offset by +$155M on resolution of a long-standing C-5 Galaxy claim. (Cash-flow “reach-forward losses” line: $1,965M.)
• 2025 (~$1.6B): $950M incremental on the Aeronautics classified (Skunk Works) program + $570M on the Canadian Maritime Helicopter Program + $95M on the Turkish Utility Helicopter Program + $140M unfavorable on C-130, partly offset by +$220M favorable on Space/Aero completions. (Cash-flow line: $1,615M.) Management framed the Q2-2025 total at ~$1.8B, ~$1.6B of which hit segment operating profit.
• 2023 was clean (reach-forward line: $45M) — the right comparison year.

The losses rotate by segment — MFC in 2024, Aeronautics + Sikorsky in 2025 — and management explicitly warns the Aeronautics classified program “may need to record additional losses.” That warning is why these cannot be cleanly waved away as one-off.

(b) The net-income-vs-operating-profit bridge (in $M):

Three silent drags explain the decline beyond the charges: (1) a ~$1.3B swing in non-service pension — from +$443M of income (2023) to an $(874)M expense (2025), the latter including a $479M non-cash pension settlement charge from a December-2025 buy-out that transferred $943M of obligations to insurers (de-risking); (2) rising interest expense (+$202M since 2023) on debt-funded buybacks; and (3) a creeping tax rate (to 15.3%, as the 2025 tax law trimmed FDII deductions).

Normalized earnings power: ~$29, roughly flat. Adding back the after-tax operating charges (~$1.6B × (1−0.153) ≈ $1.37B) and the after-tax pension settlement (~$0.41B) on ~233.5M diluted shares yields normalized 2025 EPS of ~$29; 2024 normalizes similarly (~$29). True underlying earnings power is roughly flat at ~$29, masked by ~$7/share of charges. The trailing GAAP P/E of ~26x is therefore a denominator artifact; the honest trailing multiple is ~18.7x, consistent with the ~18x forward. This is the single most important analytical point in the report.

Segment margins (the where). Ex-charges, underlying segment margins remain ~11%+. The compression is program-specific and rotating: Aeronautics fell 10.3% → 8.8% → 6.9% (classified + C-130); MFC cratered to 3.3% in 2024 (the $1.4B classified loss) then recovered to a best-in-class 13.8% in 2025; RMS fell to 7.6% (Canadian/Turkish helicopters); Space improved steadily to 10.3%.

Free cash flow. OCF was $8,557M in 2025 (vs. $6,972M in 2024, $7,920M in 2023); capex was $1,649M, giving FCF of $6,908M (138% of GAAP NI). But 2025 OCF was flattered by a ~$1.6B customer-advance build and a ~$1.55B receivables timing item, and came after an $860M discretionary pension prefund — and reach-forward losses are non-cash add-backs whose cash bleed is still ahead. Normalized run-rate FCF is closer to $5.5–6.0B. FY2026 FCF is guided to $6.5–6.8B, suppressed by a capex step-up to $2.5–2.8B (from $1.65B) plus rising IRAD — internal investment approaching ~$5B. FCF is being held down by investment, not weak operations.

Balance sheet and pension. Total debt is $21.7B (net of discounts; ~$22.9B principal), up from ~$11.7B in 2019; cash is $4,121M; net debt ~$17.6B, ~1.9x EBITDA (~1.6x on normalized EBITDA) — investment-grade and manageable but rising. Total stockholders’ equity is just $6,721M; with $11,314M of goodwill, tangible book is negative (~−$6.5B) — a function of a decade of buybacks (paid-in capital exhausted, repurchases charged to retained earnings) and a $(7,542)M pension-driven AOCL. The qualified pension is underfunded by $(3,885)M (improved from $(4,785)M in 2024; assets $22,850M; discount rate 5.375%); a 25bp lower discount rate would raise the obligation ~$700M. No required qualified contribution is expected in 2026, but ≥$1B returns in 2027 unless prefunded.

ROE/ROIC caveat. Reported ROE of ~75% (5,017/6,721) is an artifact of the thin, near-zero tangible equity base — not a quality signal — and must not be treated as one. The meaningful read is ROIC on invested capital (net debt + equity ~$24.3B): NOPAT ~$6.5B implies ~27%, and on the true tangible operating-capital base (this is a capital-light prime — capex ~2% of sales) cash returns are very high. The RTX cross-read applies: ignore GAAP ROE; use ROIC vs. WACC and normalized FCF yield.

Verdict: high underlying quality masked by a charge-driven trough, with two genuine caveats. Economics do not dramatically improve with scale (the monopsony caps margins), but they are stable and cash-generative; the FAS/CAS pension benefit currently flatters operating profit (a quality caveat), and the negative tangible book + pension overhang are real but not solvency issues. Normalized earnings are flat at ~$29 — the business is neither deteriorating nor compounding rapidly.

7. Capital Allocation

The five-year record. Over 2021–25 Lockheed returned $39.9B to shareholders — $15.2B of dividends + $24.7B of buybacks — against five-year FCF of $32.3B. That is a 124% payout, ~$7.6B more than it generated, funded with debt (total debt roughly doubled to $21.7B; interest expense rose to $1.1B). This is the defining tension: Lockheed has been distributing beyond its means and levering up to do it.

Dividends — the reliable leg. Paid dividends rose every year ($2,940M → $3,131M); per-share went $12.15 → $12.75 → $13.35, the ~23rd consecutive annual increase (raised to $3.45/quarter in late 2025). The dividend consumes ~45% of FCF and yields ~2.6% — well-covered and a genuine priority.

Buybacks — the flex variable, and it is being squeezed. Repurchases fell sharply: $4.1B (2021) → $7.9B (2022, a debt-funded Q4 accelerated share repurchase) → $6.0B (2023) → $3.7B (2024) → $3.0B (2025). Shares outstanding fell from 271M to 229M (~15%, ~3.5%/year) — a meaningful per-share tailwind that is now fading. Recent buybacks (~$455/share in 2025, ~$493 in 2024) were modestly accretive ex-post versus ~$541 today, but the genuinely value-creating repurchases were the pre-2022 ones at $330–470. The decline is both deliberate (capex step-up, balance-sheet priority) and partly forced (2024 returns were 128% of a depressed $5.3B FCF). Remaining authorization was $8.3B at year-end 2025; Q1-2026 saw a $1.0B debt retirement — an early deleveraging signal. On recent calls, analysts pressed whether the historical ~100%-of-FCF return policy is being abandoned for capex; management declined to commit, calling capital deployment “more dynamic than ever.”

M&A — and a correction worth stating plainly. Lockheed did not acquire Aerojet Rocketdyne. It announced a $4.4B deal in December 2020; the FTC moved to block it in January 2022; Lockheed terminated the merger in February 2022. L3Harris — a competitor — then bought Aerojet for ~$4.7B in 2023. Lockheed thereby lost vertical integration into solid rocket motors, and its key merchant SRM supplier is now owned by a rival; its response has been to stand up a third independent U.S. SRM source plus additive manufacturing and international co-production. The only material M&A in the five-year window is a $360M bolt-on (Amentum’s Rapid Solutions ISR business) into Space. The Marathon read: as the #1 prime, large horizontal M&A is effectively FTC-blocked, so Lockheed cannot deploy capital through transformational deals — capital returns are the residual. The discipline is genuine (no overpriced empire-building) but it reflects a structural constraint, not a strategic choice, and it removes inorganic-growth optionality.

Incentive alignment — above-average for the sector. The annual incentive (70% financial) weights 20% Sales / 40% Segment Operating Profit / 40% Free Cash Flow; the long-term incentive (70% of LTI value) weights 50% Relative TSR / 25% ROIC / 25% Free Cash Flow over three years (RSUs, 30%, time-vest). The presence of ROIC and FCF directly targets capital efficiency and per-share value — important given the thin equity and debt-funded buybacks. Two caveats: there is no absolute per-share/EPS metric anywhere, and the ROIC/FCF target levels are undisclosed (so the bar cannot be verified). Pay-for-performance did function in 2025: the Segment Operating Profit metric paid 0% (below threshold, on the Q2 program losses), though the FCF metric paid 200% (max), pulling the overall annual payout to 114%. CEO Jim Taiclet (combined Chairman/President/CEO; independent Lead Director) earned ~$23.5M total, over half in equity LTI.

Verdict: competent but constrained — not a compounding capital-allocation machine. Disciplined on price (no overpriced M&A; buybacks below the current price), a well-covered and reliably growing dividend, and ROIC/FCF/TSR in the LTI. But Lockheed over-distributed 124% of five-year FCF funded by rising debt; large M&A is blocked so capital returns are a residual; and the buyback — the historical per-share engine — is the flex variable now being squeezed by the capex ramp. Not value-destructive; not a flywheel.

8. Changes and Headwinds — Last Two Years

A timeline of what has moved the thesis since early 2024:

Negative / risk-increasing:

• March 2025 — lost NGAD/F-47 to Boeing (and reportedly the Navy F/A-XX). The single biggest thesis change: the air-dominance franchise does not extend to the next generation. Lockheed did not protest.
• 2024–25 program charges (~$3.6B). Recurring fixed-price/classified reach-forward losses — MFC classified ($1.4B, 2024), Aeronautics Skunk Works ($555M 2024 + $950M 2025, ongoing), Sikorsky Canadian/Turkish helicopters ($665M, 2025), C-130 ($140M). Real execution risk, with management warning of possible further losses.
• April 2025 — CFO change. Evan Scott replaced Jay Malave (who forfeited unvested LTI on an abrupt departure); new General Counsel in January 2025. COO Frank St. John remains. Leadership turnover at the financial helm during a charge-heavy period.
• Pension de-risking cost. A $479M non-cash settlement charge (Dec-2025) and ≥$1B of pension cash contributions returning in 2027.
• Political/headline risk. “DOGE”/Musk criticism of the F-35 (“junk,” “drones are the future”) and ~$2T lifecycle-sustainment scrutiny — not yet reflected in order cuts, but a risk to F-35 quantities.

Positive / thesis-supporting:

• Golden Dome. The homeland-missile-defense initiative — Lockheed positioning across PAC-3, THAAD, Aegis BMD (a $365M award in Q1-26), ground radars, the HELIOS laser (which neutralized four drones at sea), C2 prototyping, a space-based interceptor to fly by 2028, and a $1B+ hardened LEO tracking-layer satellite contract.
• International / munitions surge. NATO 5%-of-GDP, Germany/Poland, and Ukraine/Israel/Iran replenishment driving MFC — the highest-growth segment (mid-teens CAGR guided).
• F-35 stabilization. TR-3 hardware complete and in production; the 2024 delivery halt resolved (191 jets delivered in 2025, beating plan); Lots 18/19 definitized and Lots 20/21 in modification — over $15B of F-35 awards in Q4-2025 alone. The Pentagon’s FY27 request reportedly seeks 85 F-35s (vs. 47 prior).
• Record $193.6B backlog and a 1.2 book-to-bill — a strong near/mid-term demand floor.

Verdict: net neutral-to-slightly-negative on quality, with bifurcated risk. The NGAD loss is a genuine long-term franchise cap and the recurring charges reveal real execution risk; offsetting these, Golden Dome + international + the F-35 sustainment annuity + a record backlog provide a robust demand floor. The thesis has shifted — from “perpetual fighter monopoly” to “missile-defense + installed-base annuity” — a lower ceiling, but still durable.

9. Risk Analysis

The risk profile is not one of catastrophic downside (a diversified, government-backed, investment-grade prime); it is one of capped upside plus recurring, idiosyncratic charge/execution risk — a profile that argues for valuation discipline rather than fear.

10. Valuation Discussion (Embedded Expectations)

No price target; no recommendation. This section frames embedded expectations and scenarios only.

Multiples (at ~$541; ~229.5M shares; market cap ~$125B; net debt ~$17.6B; EV ~$142B):

The trailing GAAP P/E of ~25–26x screens “expensive” precisely because the denominator is depressed by charges — and the third-party own-history P/E percentile (88th) is trough-distorted and overstates richness. The cleaner own-history tells are P/S at the 87th and composite at the 73rd percentile — a fullish, but not extreme, valuation versus the last decade. On the honest forward/normalized basis Lockheed trades at ~18x earnings and ~13x normalized EV/EBITDA.

Peer positioning — the cheapest pure prime, but cheap for reasons:

Lockheed is the cheapest pure prime on forward P/E and sits at the low end of the prime EV/EBITDA bracket, broadly in line with Northrop and General Dynamics — despite comparable low-to-mid-single-digit growth. The discount is the market pricing real concerns: the NGAD/F-47 loss, F-35 maturity at 156/year, the fact that Lockheed is the only prime carrying ~$3.6B of recent fixed-price charges, and the decelerating buyback. This is cheap for reasons, not a clean mispricing. The bull rejoinder: MFC’s mid-teens growth, the 30% international mix, and Golden Dome optionality are not in the discounted multiple.

FY2026 guidance (verified Q4-2025, reaffirmed Q1-2026): revenue $77.5–80.0B (~5% organic), segment operating profit $8.425–8.675B (~10.9% margin), EPS $29.35–30.25, FCF $6.5–6.8B (capex $2.5–2.8B embedded). Management is explicit that ~$7 of the ~$8 year-on-year EPS increase is simply the absence of prior charges — i.e., the guide encodes a clean, post-charge base, not underlying acceleration.

Embedded-expectations / reverse-DCF. Discounting base-case FCF of ~$6.65B at ~8.5% with a 2.5% terminal growth, the ~$125B market cap implies the market is pricing only ~3.5–4% perpetual FCF growth — Lockheed as a steady, budget-capped grower, neither a re-armament supercycle winner nor a melting franchise. Sensitivity: ~2% growth ≈ $476/share; ~4% ≈ $555; ~6% ≈ $648; ~8% ≈ $755. The mispricing is directional and unresolved: bears argue even 4% is too high (monopsony cap + erosion + charges); bulls argue MFC mid-teens + international + Golden Dome support 5–6%+ blended FCF growth and the charges are episodic, making ~4% too low.

Scenarios (EPS × P/E cross-checked against FCF × P/FCF):

The key embedded-expectations conclusion: the base case sits modestly below spot. At ~$541 the stock already prices successful FY2026 execution; upside requires the supercycle to be real and the charge era to be over, while downside requires only one more charge or a budget air-pocket. The skew is roughly symmetric-to-slightly-negative at today’s price.

11. Variant Perception

Consensus view. “The highest-quality, lowest-multiple prime — a cheap, de-risked re-armament play after the 2024–25 charge reset; MFC is the growth engine; a 2.6% dividend plus a buyback underpins it.” At ~18x forward versus ~20–21x for Northrop and General Dynamics, the Street frames Lockheed as the value name in the group.

The strongest bull case. (1) Normalized ~$29 EPS at a held or modestly re-rated ~18–19x is a re-rate even without growth — you are paying a trough multiple on trough-masked earnings. (2) MFC’s mid-teens CAGR through 2030, the 30% international mix, and a Golden Dome space-based interceptor operable by 2028 are real, funded demand that the ~4%-implied-growth multiple ignores. (3) Capital return — a slowed buyback plus a 2.6% dividend on a ~5.4% FCF yield — self-funds ~8% total shareholder yield. (4) The charges are episodic and now largely behind, having been de-risked in Q2-2025.

The strongest bear case. (1) The U.S.-budget monopsony structurally caps growth (~72% of revenue from one customer growing low-single-digits, with CR/DOGE downside). (2) Franchise erosion is real and realized — Lockheed lost NGAD/F-47 to Boeing, the F-35 is stuck at 156/year, and Q1-2026 added F-16 delay and C-130 supplier issues. (3) Fixed-price-development loss risk is structural, not one-off — ~$3.6B over 2024–25, with management warning of further Skunk Works losses. (4) The balance sheet is thin and levered — net debt $17.6B, a pension overhang ($1B+ of contributions from 2027), rising interest on debt-funded buybacks. (5) The buyback — the EPS tailwind — is decelerating as capex steps up.

The 3–5 assumptions that decide it, and what falsifies each:

1. Charges are episodic, not structural. Falsified by a fourth straight year (2026/27) of fresh reach-forward losses; confirmed by clean FY26–27 with no new reach-forward line.
2. MFC’s mid-teens growth is real and funded. Falsified by PAC-3/THAAD/PrSM multi-years failing to definitize in 2026; confirmed by signed multi-years and MFC book-to-bill >1.2.
3. The market’s ~4% implied FCF growth is too low. Falsified by FCF stuck flat-to-down through 2027 as capex and pension consume growth; confirmed by FCF inflecting to $7.5B+ by 2027–28 as capex normalizes.
4. The F-35 + franchise base is stable, not eroding. Falsified by an F-35 production cut below 156 or another flagship loss; confirmed by an F-35 multi-year and the FY27 85-jet request holding.
5. The ~18x forward multiple holds. Falsified by a de-rate toward Northrop’s lower percentile if growth disappoints; confirmed by a re-rate toward General Dynamics on supercycle conviction.

The variant perception, in one line: the market is pricing Lockheed as an average low-single-digit prime; the bull says it owns an above-average missile-defense compounder hidden inside that average; the bear says the average overstates a monopsony-capped, charge-prone, franchise-eroding business. The truth is testable within 12–18 months on the charge cadence and the MFC multi-years.

12. Fact vs. Interpretation

13. Open Questions

1. Will the Aeronautics classified (Skunk Works) program take further reach-forward losses? The 10-K explicitly warns it may. This is the single biggest near-term risk to the normalized ~$29 EPS, and it is opaque (classified).
2. Is Lockheed eliminated from the Navy F/A-XX? If confirmed, Lockheed has lost both next-gen crewed fighter competitions — material to the forward franchise.
3. How much of the Golden Dome TAM does Lockheed realistically capture versus Northrop, RTX, and new-space (Anduril/SpaceX)? Management is bullish; the allocation is early and contested.
4. Does the capex step-up ($2.5–2.8B) persist or normalize? This is the swing factor for the bull “FCF inflection past $7.5B by 2027–28” case.
5. Is the historical ~100%-of-FCF capital-return policy being abandoned for capex/balance-sheet priority? Management declined to commit on recent calls.
6. How durable is the FAS/CAS pension benefit (+$1.5B to operating profit), and how much further settlement/de-risking cost is coming?
7. What is the realistic forward-revenue gap from the NGAD loss, and over what horizon? Management says “further out” and has not quantified it.

14. What Must Be True

For the bull case to work (re-rate toward Northrop/General Dynamics, ~$630–680):

• The 2024–25 charges prove episodic — no fresh reach-forward loss in FY2026–27. Falsification test: any new reach-forward line item in a 2026 or 2027 quarter breaks the “charge era is over” premise.
• MFC’s mid-teens growth is funded and definitized — PAC-3/THAAD/PrSM multi-years signed and MFC book-to-bill stays >1.2. Falsification: multi-years slip on appropriations and MFC reverts to low-single-digit growth.
• FCF inflects above ~$7.5B by 2027–28 as the capex ramp matures and pension contributions are managed. Falsification: FCF stuck flat-to-down through 2027.

For the bear case to work (de-rate to trough-prime, ~$360–420):

• A fourth straight year of program charges (the Skunk Works warning materializes), confirming fixed-price execution is a structural defect, not a cleanup. Falsification: clean FY2026, expanding ex-charge segment margins.
• A U.S. budget air-pocket (a prolonged continuing resolution, F-35 quantity cut below 156, or DOGE-driven sustainment cuts) caps growth at flat-to-down. Falsification: the FY27 85-jet F-35 request holds and appropriations pass on time.
• The franchise erosion accelerates — confirmation of the F/A-XX loss and no traction on F-35-plus/CCA. Falsification: an F-35 multi-year award and a funded CCA/F-35-plus program of record.

The two cases are distinguishable on observable evidence within 12–18 months: the charge cadence, the MFC multi-year signings, and the FCF trajectory.

15. Source Appendix

Primary filings (SEC EDGAR, CIK 0000936468):

• Lockheed Martin FY2025 Form 10-K (filed 2026-01-29) — statements of operations, segment note, MD&A “Impairment and Other Charges” and “Net FAS pension,” FCF reconciliation, Notes 1/4/10/11/12/16.
• FY2021–FY2024 Form 10-Ks (filed 2022-01-25, 2023-01-26, 2024-01-23, 2025-01-28).
• Q1-2026 Form 10-Q (filed 2026-04-23).
• DEF 14A proxy (filed 2026-03-26) — CD&A, incentive metrics, Summary Compensation Table, CFO/GC changes.
• Form 4 filings (2024–2026), sampled — codes A/M/F/S/G/I only; no code-P open-market purchases.

Earnings & event transcripts (company IR / public transcript sources, mirrored to company IR):

• Q4-2025 earnings call (2026-01-29); Q1-2026 earnings call (2026-04-23); Q2/Q3-2025 calls; Q1-2025 call (2025-04-22, NGAD).
• Bernstein Strategic Decisions Conference (2026-05-27 and 2025-05-28); Goldman Sachs Industrials (2025-12-03).
• Aerojet M&A call (2020-12-21); Q4-2021 call (2022-01-25, Aerojet termination).

Quantitative & market data:

• SEC EDGAR XBRL (companyconcept) , accessed 2026-06-12.
• Third-party fundamentals and market-data provider, accessed 2026-06-12 (news feed quiet)).
• Public market-data quote, accessed 2026-06-12 (price ~$541; market cap ~$125B; EV ~$145B; forward P/E ~17x).

Peer cross-reads (prior the author/Claude reports on disk):

• RTX (2026-06-11) — defense-prime GAAP-vs-adjusted/ROIC template, ITAR/monopsony framing, F135 sole-source, comp table.
• GE Aerospace (2026-06-10) — engine-oligopoly/aftermarket economics contrast.
• Boeing (2026-06-07) — NGAD/F-47 winner, troubled defense execution.

Public record (not in filings): NGAD/F-47 award to Boeing, USAF/White House announcement, 2025-03-21; L3Harris acquisition of Aerojet Rocketdyne (2023).

Management commentary throughout is treated as a hypothesis validated against filings, financials, and external evidence — never as evidence in itself.

APPENDIX A — Standard Diligence Questionnaire — Lockheed Martin (NYSE: LMT)

Supplemental to the research memo. Fact / Interpretation / Assumption labels where they matter.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions are: (1) Are the 2024–25 program charges a one-time cleanup or a structural fixed-price-execution defect? (2) What is the real long-term revenue/franchise cost of losing NGAD/F-47 to Boeing? (3) Is the ~100%-of-FCF capital-return model intact, or is the decelerating buyback ($7.9B→$3.0B) a permanent shift as capex steps up? (4) How much Golden Dome share does Lockheed realistically capture? (5) Is the FAS/CAS pension benefit flattering operating profit, and how durable is it? These map directly to the report’s Open Questions and What-Must-Be-True falsification tests.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? A self-inflicted trough. GAAP EPS ($21.49 in 2025, $22.31 in 2024) is depressed ~$7/share by ~$3.6B of program charges and a $479M pension settlement; normalized earnings power is ~$29 and roughly flat. This is the opposite of a cyclical peak — the depressed denominator makes the trailing P/E (~26x) screen expensive at the wrong moment (Fact, 10-K).

Driven by the external environment or internal actions? Both, but the decline is internal: revenue and orders are at record highs (external demand is excellent — $193.6B backlog), while the earnings suppression is internal (fixed-price cost overruns on classified/helicopter programs) plus below-the-line pension/interest/tax.

How stable are revenues? Highly stable — 2.5x backlog coverage, percentage-of-completion recognition on multi-decade programs, 1.2 book-to-bill, ~37% of backlog converting within 12 months.

Outlook for products/services? Solid mid-single-digit top-line growth (FY26 guide $77.5–80B, ~5%), with a genuine mid-teens compounder (MFC/missiles) inside it and optionality (Golden Dome).

How big will this market be? Growing. Global defense spending is in its strongest cycle in a generation (NATO toward 5% of GDP, munitions replenishment, homeland missile defense). International (~28% of revenue, guided toward ~30%) and missile defense are the growth pools; crewed fighters (F-35 flat at 156/year) are mature.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Broadly stable at the prime level (a five-firm oligopoly with near-zero entry), but more competitive for Lockheed specifically at the next-generation frontier — Boeing’s NGAD win and the rise of new-space entrants (Anduril, SpaceX) in Golden Dome erode Lockheed’s assumed incumbency.

How profitable is the business (ROIC, ROE)? ROE (~75%) is meaningless — a thin-equity/buyback artifact (Interpretation). The real read is ROIC ~27% on invested capital and very high cash returns on the tangible operating base (capex ~2% of sales — capital-light). But absolute margins (segment 7–14%) are monopsony-capped, well below a commercial-aero franchise.

How profitable is the industry — competitors, barriers? Moderately profitable, structurally protected. Five primes, extreme barriers (capital, clearances, ITAR, qualification), but a single buyer that audits costs and caps fees. Returns are durable but capped.

Can the business be easily understood? Yes at the segment/program level, with one caveat: classified programs (where the charges sit) are opaque by design — investors cannot independently assess the loss exposure.

Can it be undermined by foreign low-cost labor? No — ITAR, security clearances, and “buy American” sourcing wall off the U.S. defense base from offshoring.

Do brands matter? Not consumer brands, but program reputation and incumbency function as the equivalent moat — the F-35, PAC-3, THAAD, and Trident “franchises” are the brand.

Nature of competition? Winner-take-most competitive bids for new programs (high stakes, decade-defining), then sole-source incumbency and sustainment for the life of the platform. Lockheed wins on incumbency/installed base; it has lost on recent open fixed-price competitions.

Customers’ switching costs? Extremely high mid-life (training, depot, logistics, software ecosystems make re-compete impractical) — the source of the sustainment annuity. Low only at the initial platform-selection decision, which is exactly where Lockheed lost NGAD.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The installed-base sustainment annuity and program-incumbency IP are not capitalized — genuine economic value not on the balance sheet. Conversely, the $193.6B backlog is disclosed but not a balance-sheet asset.

Off-balance-sheet liabilities? The qualified pension is underfunded $(3,885)M (on-balance-sheet via AOCL, but the obligation sensitivity — $700M per 25bp of discount rate — is a tail). ≥$1B of pension cash contributions return in 2027. Reach-forward loss accruals are recognized but their cash bleed is still ahead.

How conservative is the accounting? Mixed. Reach-forward loss recognition (recognizing the full expected loss immediately) is conservative. But the FAS/CAS pension benefit flatters operating profit (+$1.5B), and percentage-of-completion accounting embeds management estimates of total program cost that have repeatedly proven optimistic (hence the charges).

How CapEx-hungry? Light historically (~2% of sales, ~$1.65B) but stepping up to $2.5–2.8B (FY26) for missile/satellite capacity — a temporary FCF suppressant.

Capital Allocation & Management

How much FCF, and how is it used? ~$6.9B (2025 reported; ~$5.5–6.0B normalized). Used for dividends (~$3.1B, growing 23 straight years) and buybacks (~$3.0B, declining). Over 2021–25, total returns were 124% of FCF, the gap debt-funded.

Philosophy? Return-the-cash (dividend priority + opportunistic buyback), constrained by an inability to do large M&A (FTC-blocked). Capital returns are a residual, not a flywheel.

Significant acquisitions recently? No — only a $360M bolt-on (Rapid Solutions). The $4.4B Aerojet bid was abandoned in 2022 (FTC); L3Harris bought Aerojet instead (Fact — corrects a common misconception).

Buying back shares? Yes, but decelerating ($7.9B 2022 → $3.0B 2025); shares down ~15% over five years. Recent repurchases (~$455–493/share) modestly accretive versus ~$541.

Issuing shares to insiders? Routine equity comp only; no dilutive issuance. SBC is immaterial to the share count trend (buybacks dominate).

Compensation policy? Annual: 20% Sales / 40% Segment Operating Profit / 40% FCF. LTI: 50% Relative TSR / 25% ROIC / 25% FCF. Above-average alignment (ROIC + FCF present), but no absolute per-share metric and undisclosed target levels. CEO Taiclet ~$23.5M, >50% equity.

Motivations of management? Pay-for-performance functioned in 2025 (Segment Op Profit metric paid 0% on the charges). Combined Chair/CEO is a mild governance negative; abrupt CFO change (Malave→Scott, Apr 2025) during a charge-heavy period bears watching.

Valuation & Market Data

ADR, MLP, or K-1? No — a standard U.S. C-corporation common stock (NYSE: LMT), 1099 dividend reporting.

Dividend policy? ~$13.80/year run-rate (~2.6% yield), ~45% of FCF, 23rd consecutive annual increase — a core priority and well-covered.

How profitable? Stable mid-single-digit-margin business at the operating line (10.3% consolidated, monopsony-capped); high cash ROIC on a capital-light base.

Is net income diverging from cash from operations? Yes, favorably — OCF ($8.56B) far exceeds GAAP NI ($5.0B) because the charges are partly non-cash accruals and working capital (customer advances) provided a tailwind. Quality caveat: that working-capital tailwind and the non-cash charge add-backs mean reported FCF currently overstates normalized cash generation somewhat.

Risks & Downside

What would cause the stock to decline? A fresh program charge (the Skunk Works warning), a U.S. budget air-pocket / F-35 quantity cut, confirmation of the F/A-XX loss, FCF stuck flat as capex/pension consume it, or a multiple de-rate if MFC growth disappoints. (Memo,.)

Risk of a catastrophic loss? Very low — a diversified, government-backed, investment-grade prime with $193.6B of contracted backlog. No realistic path to equity impairment.

Chance of a total loss? Negligible. The risk is capped upside plus recurring idiosyncratic charge risk, not solvency.

Recent News & Events

Has the business environment changed recently? Yes, in two directions: demand has strengthened materially (NATO 5%, munitions replenishment, Golden Dome), while Lockheed’s competitive position at the frontier weakened (lost NGAD/F-47 to Boeing, March 2025).

Significant acquisitions? No (see above).

Change in accounting policies? No material change; the pension de-risking (a $479M settlement) is a transaction, not a policy change.

Recent changes — markets, facilities, management? New CFO (Evan Scott, April 2025) and General Counsel (January 2025); capex ramp for missile/satellite capacity; a third independent solid-rocket-motor source standing up to replace the lost Aerojet relationship; aggressive Golden Dome and F-35-plus positioning.

APPENDIX B — Source Appendix — Lockheed Martin (NYSE: LMT)

Primary sources before secondary; recent before stale. Management commentary is treated as hypothesis, validated against filings and external evidence.

Primary regulatory filings (SEC EDGAR, CIK 0000936468)

Earnings & event transcripts (company earnings and event-call transcripts)

Quantitative & market data

Public record (not in filings)

• NGAD / F-47 sixth-gen fighter awarded to Boeing — USAF / White House announcement, 2025-03-21.
• L3Harris acquisition of Aerojet Rocketdyne (~$4.7B), closed 2023 — the company Lockheed could not buy.

Methodology notes

• Revenue tag: Lockheed reports under the legacy XBRL Revenues tag; the modern RevenueFromContractWithCustomerExcludingAssessedTax tag stops at 2019.
• Normalization: Reported GAAP EPS ($21.49 in 2025) is adjusted to a normalized ~$29 by adding back after-tax reach-forward losses (~$1.37B) and the after-tax pension settlement (~$0.41B) on ~233.5M diluted shares. The trailing GAAP P/E (~26x) is therefore charge-distorted; the honest multiple is ~18x forward.
• Net debt reconciliation: a public market-data feed reported cash $1.9B (stale); the FY2025 10-K balance sheet shows cash $4,121M and total debt $21.7B → net debt ~$17.6B.
• ROE caveat: reported ROE ~75% is a thin-equity/buyback artifact (tangible book negative ~−$6.5B); ROIC (~27%) and normalized FCF yield are the meaningful return measures.